Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
Wolf VLW, Breder I, de Carvalho LSF, Soares AAS, Cintra RM, Barreto J, Munhoz DB, Kimura-Medorima ST, Nadruz W, Guerra-Júnior G, Quinaglia T, Muscelli E, Sposito AC; Addenda-BHS2 trial investigators. Wolf VLW, et al. Among authors: quinaglia t. Nutr Diabetes. 2021 Jun 12;11(1):17. doi: 10.1038/s41387-021-00160-5. Nutr Diabetes. 2021. PMID: 34120150 Free PMC article. Clinical Trial.
Peri-infarct zone characterized by cardiac magnetic resonance imaging is directly associated with the inflammatory activity during acute phase myocardial infarction.
Quinaglia e Silva JC, Coelho-Filho OR, Andrade JM, Quinaglia T, Modolo RG, Almeida BO, van der Geest RJ, Jerosch-Herold M, Coelho OR, Sposito AC; Brasilia Heart Study Group. Quinaglia e Silva JC, et al. Among authors: quinaglia t. Inflammation. 2014 Jun;37(3):678-85. doi: 10.1007/s10753-013-9784-y. Inflammation. 2014. PMID: 24282109 Free article.
Short-term effects of extended-release niacin with and without the addition of laropiprant on endothelial function in individuals with low HDL-C: a randomized, controlled crossover trial.
Nasser Figueiredo V, Vendrame F, Colontoni BA, Quinaglia T, Roberto Matos-Souza J, Azevedo Moura F, Coelho OR, de Faria EC, Sposito AC. Nasser Figueiredo V, et al. Among authors: quinaglia t. Clin Ther. 2014 Jun 1;36(6):961-6. doi: 10.1016/j.clinthera.2014.03.012. Epub 2014 Apr 24. Clin Ther. 2014. PMID: 24768191 Clinical Trial.
Flow-mediated dilation: An evolving method.
Quinaglia T, Matos-Souza JR, Feinstein SB, Sposito AC. Quinaglia T, et al. Atherosclerosis. 2015 Jul;241(1):143-4. doi: 10.1016/j.atherosclerosis.2015.05.004. Epub 2015 May 9. Atherosclerosis. 2015. PMID: 25982823 No abstract available.
Diabetic cardiomyopathy: factual or factoid?
Quinaglia T, Oliveira DC, Matos-Souza JR, Sposito AC. Quinaglia T, et al. Rev Assoc Med Bras (1992). 2019 Jan;65(1):61-69. doi: 10.1590/1806-9282.65.1.69. Rev Assoc Med Bras (1992). 2019. PMID: 30758422 Free article. Review.
Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial.
Cintra RMR, Soares AAS, Breder I, Munhoz DB, Barreto J, Kimura-Medorima ST, Cavalcante P, Zanchetta R, Breder JC, Moreira C, Virginio VW, Bonilha I, Lima-Junior JC, Coelho-Filho OR, Wolf VLW, Guerra-Junior G, Oliveira DC, Haeitmann R, Fernandes VHR, Nadruz W, Chaves FRP, Arieta CEL, Quinaglia T, Sposito AC; ADDENDA-BHS2 trial investigators. Cintra RMR, et al. Among authors: quinaglia t. Diabetol Metab Syndr. 2019 Jul 31;11:62. doi: 10.1186/s13098-019-0457-3. eCollection 2019. Diabetol Metab Syndr. 2019. PMID: 31384310 Free PMC article.
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial.
Breder I, Cunha Breder J, Bonilha I, Munhoz DB, Medorima STK, Oliveira DC, do Carmo HR, Moreira C, Kontush A, Zimetti F, Zanotti I, Carvalho LSF, Nadruz W, Muscelli E, Quinaglia T, Sposito AC; EXCEED-BHS3 Trial Investigator. Breder I, et al. Among authors: quinaglia t. Ther Adv Chronic Dis. 2020 Sep 28;11:2040622320959248. doi: 10.1177/2040622320959248. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 33062236 Free PMC article.
Coronavirus disease-19: The multi-level, multi-faceted vasculopathy.
Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Quinaglia T, et al. Atherosclerosis. 2021 Apr;322:39-50. doi: 10.1016/j.atherosclerosis.2021.02.009. Epub 2021 Feb 15. Atherosclerosis. 2021. PMID: 33706082 Free PMC article. Review.
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.
Sposito AC, Breder I, Soares AAS, Kimura-Medorima ST, Munhoz DB, Cintra RMR, Bonilha I, Oliveira DC, Breder JC, Cavalcante P, Moreira C, Moura FA, de Lima-Junior JC, do Carmo HRP, Barreto J, Nadruz W, Carvalho LSF, Quinaglia T; ADDENDA-BHS2 trial investigators. Sposito AC, et al. Among authors: quinaglia t. Cardiovasc Diabetol. 2021 Mar 26;20(1):74. doi: 10.1186/s12933-021-01264-z. Cardiovasc Diabetol. 2021. PMID: 33771149 Free PMC article. Clinical Trial.
43 results